Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.72 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. Retractable Technologies has a twelve month low of $0.70 and a twelve month high of $1.34. The firm’s 50 day moving average price is $0.81 and its two-hundred day moving average price is $0.98. The firm has a market cap of $21.66 million, a P/E ratio of -1.19 and a beta of 2.06.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The business had revenue of $6.03 million during the quarter.

Insider Buying and Selling

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were purchased at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now directly owns 14,743,907 shares in the company, valued at approximately $12,090,003.74. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last three months, insiders have bought 176,179 shares of company stock worth $144,814. Insiders own 55.00% of the company’s stock.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.